Effect of P-glycoprotein Inhibitor (Carvedilol) on Developmental Outcome Methotrexate are Given Alone and in Combination of Pregnant Rats
This study was performed according to FDA protocol to evaluate the developmental effects of carvedilol (P-glycoprotein inhibitor), methotrexate (P-glycoprotein substrate) and their combination at therapeutic doses on pregnant rats. Sixty Albino Wistar rats (40 female rats and 20 males) were...
Main Authors: | Zaid K Shnawa, Duraid A Abass |
---|---|
Format: | Article |
Language: | English |
Published: |
University of Baghdad, College of Veterinary Medicine
2022-12-01
|
Series: | The Iraqi Journal of Veterinary Medicine |
Subjects: | |
Online Access: | https://jcovm.uobaghdad.edu.iq/index.php/Iraqijvm/article/view/1410 |
Similar Items
-
A simple LC-MS/MS method for pharmacokinetic study of carvedilol and 4/-hydroxyphenyl carvedilol at a low dose
by: Wanna Eiamart, et al.
Published: (2022-01-01) -
The Role of Carvedilol in the Treatment of Dilated and Anthracyclines-Induced Cardiomyopathy
by: Makoto Kodama, et al.
Published: (2011-05-01) -
Transfersome Encapsulated with the R-carvedilol Enantiomer for Skin Cancer Chemoprevention
by: Md Abdullah Shamim, et al.
Published: (2023-03-01) -
R-carvedilol, a potential new therapy for Alzheimer’s disease
by: Jinjing Yao, et al.
Published: (2022-11-01) -
BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL
by: A. N. Zakirova, et al.
Published: (2016-01-01)